Wei, H., Cui, C., Cui, X., Liu, Y., & Li, D. (2021). Cost‐effectiveness analysis of dabigatran, rivaroxaban and warfarin in the prevention of stroke in patients with atrial fibrillation in China. BMC Health Serv Res.
Citação norma ChicagoWei, Hongtao, Can Cui, Xiangli Cui, Yi Liu, and Dandan Li. "Cost‐effectiveness Analysis of Dabigatran, Rivaroxaban and Warfarin in the Prevention of Stroke in Patients With Atrial Fibrillation in China." BMC Health Serv Res 2021.
Citação norma MLAWei, Hongtao, et al. "Cost‐effectiveness Analysis of Dabigatran, Rivaroxaban and Warfarin in the Prevention of Stroke in Patients With Atrial Fibrillation in China." BMC Health Serv Res 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.